Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Ritlecitinib was generally well tolerated in children with alopecia areata.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

A patient's grey hair regained color during treatment with adalimumab.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Some tuberculosis drugs may cause hair loss, but hair might regrow after treatment or changing the drugs.

ITK inhibitors may effectively treat alopecia areata.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

A 12-year-old boy had severe shingles and skin damage after a stem-cell transplant.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Certain patient characteristics can help predict hair regrowth success with ritlecitinib in alopecia areata.